RxDoctor Payments Data

Arthur Wood, MD

General Practice · Waynesboro, MSNPI 1699718981

Payments from drug & device makers

$1,260in general payments, 2019–2025

Across 78 payments — averaging $16.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$293
  • AstraZeneca$136
  • Pfizer$129
  • Lilly USA, LLC$94
  • Novartis$76
  • Hikma Pharmaceuticals USA$70
  • plus $461 from 13 others

What the payments were for

  • Food & beverage$1,260100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,260 in reported general payments places this provider in the 75th percentile of 674 general practice providers in Mississippi.

See all general practice providers in Mississippi

Medicare billing

Part B allowed, 2024
$4,567
Medicare patients
15
Services billed
51

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide167$150,086
EliquisApixaban80$65,050
MounjaroTirzepatide42$61,524
TriumeqAbacavir/Dolutegravir/Lamivudi13$55,397
FarxigaDapagliflozin Propanediol66$46,910
LinzessLinaclotide54$45,771
JardianceEmpagliflozin38$34,652
XareltoRivaroxaban33$26,719
JanuviaSitagliptin Phosphate14$17,576
JanumetSitagliptin Phos/Metformin Hcl11$12,876
Tresiba Flextouch U-200Insulin Degludec16$9,384
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$6,878
Breztri AerosphereBudesonide/Glycopyr/Formoterol11$6,811
TradjentaLinagliptin12$5,896
Lantus SolostarInsulin Glargine,hum.Rec.Anlog44$5,658

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$47$150,086167 claims
PfizerEliquis$129$65,05080 claims
Lilly USA, LLCMounjaro$94$61,52442 claims
AstraZenecaFarxiga, Breztri Aerosphere$136$53,72177 claims
AbbVieLinzess$293$45,77154 claims
Boehringer IngelheimJardiance, Tradjenta$19$40,54850 claims
MerckJanuvia, Janumet$49$30,45225 claims
Johnson & JohnsonXarelto$60$26,71933 claims
GSKTrelegy Ellipta$42$6,87811 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 674 general practice providers in Mississippi.

Other general practice in Waynesboro

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →